…nder, Biden Cancer Initiative Select Speakers & Panelists DR. BAHIJA JALLAL Head, MedImmune | Executive Vice President, AstraZeneca MR. GREGORY SIMON President, Biden Cancer Initiative, Biden Foundation DR. GÖRAN K. HANSSON Secretary General, The Royal Swedish Academy of Sciences...
Results for “AstraZeneca”
Search across the indexed text of every released document.
Names that match “AstraZeneca”
5 documents found
…er, Biden Cancer Initiative Select Speakers & Panelists DR. BAHIJA JALLAL Head, MedImmune | Executive Vice President, AstraZeneca MR. GREGORY SIMON President, Biden Cancer Initiative, Biden Foundation DR. GORAN K. HANSSON Secretary General, The Royal Swedish Academy of Scienc...
…Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and Pearl Therapeutics (acquired by AstraZeneca in 2012). Prior to joining Sprout, Jim was Chief Science and Technology Officer for GlaxoSmithKline (“GSK”). From 1995 to 2001, he led Global Resear...
…Therapeutics (acquired by Novartis in 2010), where he served as Executive Chairman, and Pearl Therapeutics (acquired by AstraZeneca in 2012). Prior to joining Sprout, Jim was Chief Science and Technology Officer for GlaxoSmithKline (“GSK”). From 1995 to 2001, he led Global Resear...
…BANK - BROKERAGE ACCOUNT - HOLDINGS I AT&T INC NIA None (or less than $1 ,001) Dividends.Capital Gain $2,501 - $5,000 2 ASTRAZENECA PLC ADR NIA None (or less than $1 ,001) Capital Gain $201 - $1 ,000 3 CROWN CASTLE INTL CORP NIA None (or less than $1 ,001) Dividends.Capital Gain...